Company has strong R&D capability and technique reserve. Cooperating with Chinese Academy of Science Institute of Drug and Fudan University, we have established a high-quality R&D team. There are a number of engineers with rich experience and onsciousness of innovation in the team, and they have capability to design synthesis routes independently. Currently company is charged with two fund R&D topics, and possesses a technology invention patent, and also takes charge of a tackle key project in Shanghai, Semi-synthesis Industrialization Low-cost Research of Anti-cancer API Hydroxycamptothecin.